These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32315368)

  • 1. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis.
    Yamamoto-Furusho JK; Mendieta-Escalante EA
    PLoS One; 2020; 15(4):e0231988. PubMed ID: 32315368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis.
    Celikbilek M; Dogan S; Ozbakır O; Zararsız G; Kücük H; Gürsoy S; Yurci A; Güven K; Yücesoy M
    J Clin Lab Anal; 2013 Jan; 27(1):72-6. PubMed ID: 23292894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil and Eosinophil Granule Proteins as Potential Biomarkers of Assessing Disease Activity and Severity in Patients With Ulcerative Colitis.
    Li Z; Long Y; Bai M; Li J; Feng Z
    J Clin Lab Anal; 2016 Sep; 30(5):776-8. PubMed ID: 27076259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
    Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?
    Posul E; Yilmaz B; Aktas G; Kurt M
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):262-5. PubMed ID: 25576331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis.
    Demir AK; Demirtas A; Kaya SU; Tastan I; Butun I; Sagcan M; Sahin S; Tasliyurt T; Yilmaz A
    Kaohsiung J Med Sci; 2015 Nov; 31(11):585-90. PubMed ID: 26678939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
    Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.
    Bálint A; Farkas K; Szepes Z; Nagy F; Szűcs M; Tiszlavicz L; Bor R; Milassin Á; Rutka M; Fábián A; Molnár T
    BMC Gastroenterol; 2018 Jan; 18(1):7. PubMed ID: 29310593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity.
    Torun S; Tunc BD; Suvak B; Yildiz H; Tas A; Sayilir A; Ozderin YO; Beyazit Y; Kayacetin E
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):491-7. PubMed ID: 22841412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.
    Hanai H; Takeuchi K; Iida T; Kashiwagi N; Saniabadi AR; Matsushita I; Sato Y; Kasuga N; Nakamura T
    Dig Dis Sci; 2004 Sep; 49(9):1438-43. PubMed ID: 15481316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Brandse JF; Bennink RJ; van Eeden S; Löwenberg M; van den Brink GR; DʼHaens GR
    Inflamm Bowel Dis; 2016 Jun; 22(6):1384-90. PubMed ID: 26978724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.